Top

BMC Public Health

Published in:

Open Access 01-12-2014 | Research article

Causes of death and associated risk factors among climacteric women from Southern Brazil: a population based-study

Authors: Verônica Colpani, Karen Oppermann, Poli Mara Spritzer

Published in: BMC Public Health | Issue 1/2014

Abstract

Background

Aging and menopause are particular cardiovascular risk factors for women, due to estrogen deprivation at the time of menopause. Studies show that diabetes mellitus (DM), smoking, hypertension, high body mass index (BMI), and serum lipids are associated with increased risk of cardiovascular disease (CVD), the main cause of female mortality in Brazil. The aim of this study was to assess the mortality rate, causes of death and associated risk factors in a cohort of women from Brazil.

Methods

A longitudinal population-based study of menopausal status is currently underway in a city in South Brazil. In 2010, a third follow-up of this population was performed to assess cardiovascular risk and mortality rate between 1995 and 2011. For this analysis, 358 participants were studied. At baseline, participants had completed a standardized questionnaire including demographic, lifestyle, medical and reproductive characteristics. In addition to the contacts with relatives, mortality data were obtained through review of medical records in all city hospitals and the Center for Health Information (NIS/RS-SES). Multivariate-adjusted hazard risk (HR) and 95% confidence intervals (CI95%) were estimated using Cox proportional hazards regression. Survival curves were estimated using the Kaplan-Meier curve.

Results

There were 17 (4.7%) deaths from all causes during the study period. Seven (41.2%) deaths were caused by CVD, including four cases of stroke and three cases of myocardial infarction. Six (35.3%) deaths were due to cancer, and four (23.5%) were due to other reasons. In the age and smoking-adjusted multivariate models, diabetes (HR 6.645, 95% CI: 1.938–22.79, p = 0.003), alcohol intake (HR 1.228, 95% CI: 1.014-1.487, p = 0.035) and postmenopausal status (HR = 6.216, 95% CI: 0.963–40.143, p = 0.055) were associated with all-cause mortality. A significant association was found between abdominal obesity (WHR ≥ 0.85) and mortality even after the adjustment for BMI (HR = 9.229, 95% IC: 2.083–41.504, p = 0.003).

Conclusion

CVD was an important cause of mortality in this cohort and DM and/or central adiposity were associated with all-cause mortality. Lifestyle and dietary factors seem to be related to risk of mortality in middle-aged women.

Available only for authorised users

Instituto Brasileiro de Geografia e Estatística: Brasil: tábua completa de mortalidade - 2010. Gerência de Estudos e Análises da Dinâmica Demográfica - GEADD. Edited by: Diretoria de Pesquisas – DPE, Coordenação de População e Indicadores Sociais – COPIS. 2011, Rio de Janeiro: IBGE

Cabrera M, Gebara O, Diament J, Nussbacher A, Rosano G, Wajngarten M: Metabolic syndrome, abdominal obesity, and cardiovascular risk in elderly women. Int J Cardiol. 2007, 114: 224-229. 10.1016/j.ijcard.2006.01.019.CrossRefPubMed

Cabrera M, Wajngarten M, Gebara O, Diament J: Relationship between body mass index, waist circumference, and waist-to-hip ratio and mortality in elderly women: a 5-year follow-up study. Cad Saude Publica. 2005, 21: 767-775. 10.1590/S0102-311X2005000300010.CrossRefPubMed

He L, Tang X, Li N, Wu YQ, Wang JW, Li JR, Zhang ZX, Dou HD, Liu JJ, Yu LP, Xu HT, Zhang JG, Hu YH: Menopause with cardiovascular disease and its risk factors among rural Chinese women in Beijing: a population-based study. Maturitas. 2012, 72: 132-138. 10.1016/j.maturitas.2012.02.013.CrossRefPubMed

Hu F, Stampfer M, Solomon C, Liu S, Willett W, Speizer F, Nathan D, Manson J: The impact of diabetes mellitus on mortality from all causes and coronary heart disease in women: 20 years of follow-up. Arch Intern Med. 2001, 161: 1717-1723. 10.1001/archinte.161.14.1717.CrossRefPubMed

Campbell P, Newton C, Patel A, Jacobs E, Gapstur S: Diabetes and cause-specific mortality in a prospective cohort of one million U.S. adults. Diabetes Care. 2012, 35: 1835-1844. 10.2337/dc12-0002.CrossRefPubMedPubMedCentral

Corrêa P, Barreto S, Passos V: Smoking-attributable mortality and years of potential life lost in 16 Brazilian capitals, 2003: a prevalence-based study. BMC Public Health. 2009, 26: 206-CrossRef

Eichner J, Wang W, Zhang Y, Lee E, Welty T: Tobacco use and cardiovascular disease among American Indians: the strong heart study. Int J Environ Res Public Health. 2010, 7: 3816-3830. 10.3390/ijerph7103816.CrossRefPubMedPubMedCentral

Ezzati M, Oza S, Danaei G, Murray C: Trends and cardiovascular mortality effects of state-level blood pressure and uncontrolled hypertension in the United States. Circulation. 2008, 117: 905-914. 10.1161/CIRCULATIONAHA.107.732131.CrossRefPubMed

10.

Baer H, Glynn R, Hu F, Hankinson S, Willett W, Colditz A, Stampfer M, Rosner B: Risk factors for mortality in the nurses’ health study: a competing risks analysis. Am J Epidemiol. 2011, 173: 319-329. 10.1093/aje/kwq368.CrossRefPubMed

11.

Manson J, Willett W, Stampfer M, Colditz G, Hunter D, Hankinson S, Hennekens C, Speizer F: Body weight and mortality among women. N Engl J Med. 1995, 333: 677-685. 10.1056/NEJM199509143331101.CrossRefPubMed

12.

Klenk J, Nagel G, Ulmer H, Strasak A, Concin H, Diem G, Rapp K, VHM&PP Study Group: Body mass index and mortality: results of a cohort of 184,697 adults in Austria. Eur J Epidemiol. 2009, 24: 83-91. 10.1007/s10654-009-9312-4.CrossRefPubMed

13.

Sasazuki S, Inoue M, Tsuji I, Sugawara Y, Tamakoshi A, Matsuo K, Wakai K, Nagata C, Tanaka K, Mizoue T, Tsugane S, Research Group for the Development and Evaluation of Cancer Prevention Strategies in Japan: Body mass index and mortality from all causes and major causes in Japanese: results of a pooled analysis of 7 large-scale cohort studies. J Epidemiol. 2011, 21: 417-430. 10.2188/jea.JE20100180.CrossRefPubMedPubMedCentral

14.

Lewington S, Whitlock G, Clarke R, Sherliker P, Emberson J, Halsey J, Qizilbash N, Peto R, Collins R, Prospective Studies Collaboration: Blood cholesterol and vascular mortality by age, sex, and blood pressure: a meta-analysis of individual data from 61 prospective studies with 55,000 vascular deaths. Lancet. 2007, 370: 1829-1839.CrossRefPubMed

15.

Duncan B, Stevens A, Iser B, Malta D, Silva G, Schmidt M: Mortalidade por doenças crônicas no Brasil: situação em 2009 e tendências de 1991 a 2009. Saúde Brasil 2010: uma análise da situação de saúde e de evidências selecionadas de impacto de ações de vigilância em saúde. Edited by: Ministério da Saúde, Secretaria de Vigilância em Saúde, Departamento de Análise de Situação em Saúde, vol. 1. 2011, Brasília: Ministério da Saúde, 117-133.

16.

Mansur A, Favarato D: Mortalidade por doenças cardiovasculares no Brasil e na região metropolitana de São Paulo: atualização 2011. Arq Bras Cardiol. 2012, 99: 755-761. 10.1590/S0066-782X2012005000061.CrossRef

17.

Haddad N, Silva M: Mortality due to cardiovascular disease in women during the reproductive age (15 to 49 years), in the State of São Paulo, Brazil, from 1991 to 1995. Arq Bras Cardiol. 2000, 75: 375-379.CrossRefPubMed

18.

Curioni C, Cunha C, Veras R, André C: The decline in mortality from circulatory diseases in Brazil. Rev Panam Salud Publica. 2009, 25: 9-15.CrossRefPubMed

19.

Bevilacqua M, Gimeno S: Abdominal obesity in Japanese-Brazilians: which measure is best for predicting all-cause and cardiovascular mortality?. Cad Saude Publica. 2011, 27: 1986-1996.PubMed

20.

Oppermann-Lisboa K, Fuchs S, Spritzer P: Premenopause cross sectional study: sexual hormones profile, age and body mass index. A population based study. Gynecol Endocrinol. 1999, 13: 171-[ABSTRACT]

21.

Oppermann K, Fuchs S, Spritzer P: Ovarian volume in pre- and perimenopausal women: a population-based study. Menopause. 2003, 10: 209-213. 10.1097/00042192-200310030-00006.CrossRefPubMed

22.

Bastos C, Oppermann K, Fuchs S, Donato G, Spritzer P: Determinants of ovarian volume in pre-, menopausal transition, and post-menopausal women: a population-based study. Maturitas. 2006, 53: 405-412. 10.1016/j.maturitas.2005.07.002.CrossRefPubMed

23.

CID-10 Classificação estatística internacional de doenças e problemas relacionados à saúde: 10a rev. [http://www.datasus.gov.br/cid10/v2008/cid10.htm]

24.

Moreira L, Fuchs F, Moraes R, Bredemeier M, Cardozo S, Fuchs S, Victora C: Alcoholic beverage consumption and associated factors in Porto Alegre, a Southern Brazilian city: a population-based survey. J Stud Alcohol. 1996, 57: 253-259.CrossRefPubMed

25.

Kriska A: Modifiable activity questionnaire. J Am Coll Sports Med. 1995, 29: 73-78.

26.

Ainsworth B, Haskell W, Whitt M, Irwin M, Swartz A, Strath S, O’Brien W, Bassett DJ, Schmitz K, Emplaincourt P, Jacobs DJ, Leon A: Compendium of physical activities: an update of activity codes and MET intensities. Med Sci Sports Exerc. 2000, 32: 498-504. 10.1097/00005768-200009001-00009.CrossRef

27.

Colpani V, Oppermann K, Spritzer P: Association between habitual physical activity and lower cardiovascular risk in premenopausal, perimenopausal, and postmenopausal women: a population-based study. Menopause. 2012, in press

28.

World Health Organization: Physical status: the use and interpretation of anthropometry. Report of the WHO Expert Committee. World Health Organ Tech Rep Ser. 1995, Geneva: World Health Organization, 1-452.

29.

World Health Organization: Obesity: preventing and managing the global epidemic. Report of a WHO consultation on obesity. World Health Organ Tech Rep Ser. 1998, Geneva: World Health Organization, 1-234.

30.

Lohman T, Roche A, Martorelli R: Anthropometric Standardization Reference Manual. 1988, Champaign, IL: Human Kinetics Books

31.

Foucan L, Hanley J, Deloumeaux J, Suissa S: Body mass index (BMI) and waist circumference (WC) as screening tools for cardiovascular risk factors in Guadeloupean women. J Clin Epidemiol. 2002, 55: 990-996. 10.1016/S0895-4356(02)00430-4.CrossRefPubMed

32.

Chobanian A, Bakris G, Black H, Cushman W, Green L, Izzo J, Jones D, Materson B, Oparil S, Wright J, Roccella E, National High Blood Pressure Education Program Coordinating Committee: Seventh report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure. JAMA. 2003, 289: 2560-2572. 10.1001/jama.289.19.2560.CrossRefPubMed

33.

Friedewald W, Levy R, Fredrickson D: Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972, 18: 499-502.PubMed

34.

Oppermann K, Fuchs SC, Spritzer PM: Androgenous androgens, ovarian volume and cardiovascular risk factors in pre-, menopause transition and post-menopause: a longitudinal study. 23rd Annual Meeting - NAMS - The North American Menopause Society: 2012; Orlando, Florida, USA. 2012, Ohio: Mayfield Heights, 59-60. [ABSTRACT]

35.

Carlsson C, Stein J: Cardiovascular disease and the aging woman: overcoming barriers to lifestyle changes. Curr Womens Health Rep. 2002, 2: 366-372.PubMed

36.

Schmitt A, Cardoso M, Aldrighi J: Tendências da mortalidade em mulheres brasileiras no climatério. Rev Bras Crescimento Desenvolv Hum. 2008, 18: 11-15.

37.

Huxley R, Barzi F, Woodward M: Excess risk of fatal coronary heart disease associated with diabetes in men and women: meta-analysis of 37 prospective cohort studies. BMJ. 2006, 332: 332-373. 10.1136/bmj.38726.404120.7C.CrossRef

38.

Barreto SM, Passos VM, Almeida SK, Assis TD: The increase of diabetes mortality burden among Brazilian adults. Rev Panam Salud Publica. 2007, 22: 239-245. 10.1590/S1020-49892007000900003.CrossRefPubMed

39.

Lee C, Joseph L, Colosimo A, Dasgupta K: Mortality in diabetes compared with previous cardiovascular disease: a gender-specific meta-analysis. Diabetes Metab. 2012, 38: 420-427. 10.1016/j.diabet.2012.04.002.CrossRefPubMed

40.

Kannel W: The Framingham Study: historical insight on the impact of cardiovascular risk factors in men versus women. J Gend Specif Med. 2002, 5: 27-37.PubMed

41.

Steingart RM, Packer M, Hamm P, Coglianese ME, Gersh B, Geltman EM, Sollano J, Katz S, Moye L, Basta LL, Lewis SJ, Gottlieb SS, Bernstein V, McEwan P, Jacobson K, Brown EJ, Kukin ML, Kantrowitz NE, Pfeffer MA, and the Survival and Ventricular Enlargement Investigators: Sex differences in the management of coronary artery disease. Survival and Ventricular Enlargement Investigators. N Engl J Med. 1991, 325: 226-230. 10.1056/NEJM199107253250402.CrossRefPubMed

42.

Stranges S, Guallar E: Cardiovascular disease prevention in women: a rapidly evolving scenario. Nutr Metab Cardiovasc Dis. 2012, 22: 1013-1018. 10.1016/j.numecd.2012.10.001.CrossRefPubMed

43.

Walden CE, Knopp RH, Wahl PW, Beach KW, Strandness E: Sex differences in the effect of diabetes mellitus on lipoprotein triglyceride and cholesterol concentrations. N Engl J Med. 1984, 311: 953-959. 10.1056/NEJM198410113111505.CrossRefPubMed

44.

Siegel RD, Cupples A, Schaefer EJ, Wilson PW: Lipoproteins, apolipoproteins, and low-density lipoprotein size among diabetics in the Framingham offspring study. Metabolism. 1996, 45: 1267-1272. 10.1016/S0026-0495(96)90246-2.CrossRefPubMed

45.

Cardillo C, Campia U, Bryant M, Panza J: Increased activity of endogenous endothelin in patients with type II diabetes mellitus. Circulation. 2002, 106: 1783-1787. 10.1161/01.CIR.0000032260.01569.64.CrossRefPubMed

46.

Cosentino F, Eto M, De Paolis P, van der Loo B, Bachschmid M, Ullrich V, Kouroedov A, Delli Gatti C, Joch H, Volpe M, Lüscher T: High glucose causes upregulation of cyclooxygenase-2 and alters prostanoid profile in human endothelial cells. Circulation. 2003, 107: 1017-1023. 10.1161/01.CIR.0000051367.92927.07.CrossRefPubMed

47.

Flegal K, Graubard B, Williamson D, Gail M: Excess deaths associated with underweight, overweight, and obesity. JAMA. 2005, 293: 1861-1867. 10.1001/jama.293.15.1861.CrossRefPubMed

48.

Calle E, Thun M, Petrelli J, Rodriguez C, Heath CJ: Body-mass index and mortality in a prospective cohort of U.S. adults. N Engl J Med. 1999, 341: 1097-1105. 10.1056/NEJM199910073411501.CrossRefPubMed

49.

Allison D, Faith M, Heo M, Kotler D: Hypothesis concerning the U-shaped relation between body mass index and mortality. Am J Epidemiol. 1997, 146: 339-349. 10.1093/oxfordjournals.aje.a009275.CrossRefPubMed

50.

Schneider HJ, Friedrich N, Klotsche J, Pieper L, Nauck M, John U, Dorr M, Felix S, Lehnert H, Pittrow D, Silber S, Volzke H, Stalla GK, Wallaschofski H, Wittchen HU: The predictive value of different measures of obesity for incident cardiovascular events and mortality. J Clin Endocrinol Metab. 2010, 95: 1777-1785. 10.1210/jc.2009-1584.CrossRefPubMed

51.

Hotchkiss JW, Leyland AH: The relationship between body size and mortality in the linked Scottish Health Surveys: cross-sectional surveys with follow-up. Int J Obes. 2011, 35: 838-851. 10.1038/ijo.2010.207.CrossRef

52.

Srikanthan P, Seeman TE, Karlamangla AS: Waist-hip-ratio as a predictor of all-cause mortality in high-functioning older adults. Ann Epidemiol. 2009, 19: 724-731. 10.1016/j.annepidem.2009.05.003.CrossRefPubMedPubMedCentral

53.

Mosca L, Appel L, Benjamin E, Berra K, Chandra-Strobos N, Fabunmi R, Grady D, Haan C, Hayes S, Judelson D, Keenan N, McBride P, Oparil S, Ouyang P, Oz M, Mendelsohn M, Pasternak R, Pinn V, Robertson R, Schenck-Gustafsson K, Sila C, Smith SJ, Sopko G, Taylor A, Walsh B, Wenger N, Williams C: Evidence-based guidelines for cardiovascular disease prevention in women. Circulation. 2004, 109: 672-693. 10.1161/01.CIR.0000114834.85476.81.CrossRefPubMed

54.

Marjoribanks J, Farquhar C, Roberts H, Lethaby A: Long term hormone therapy for perimenopausal and postmenopausal women. Cochrane Database Syst Rev. 2012, 7: CD004143

55.

Hulley S, Grady D, Bush T, Furberg C, Herrington D, Riggs B, Vittinghoff E: Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group. JAMA. 1998, 280: 605-613. 10.1001/jama.280.7.605.CrossRefPubMed

56.

Simon JA, Hsia J, Cauley JA, Richards C, Harris F, Fong J, Barrett-Connor E, Hulley SB: Postmenopausal hormone therapy and risk of stroke: The Heart and Estrogen-progestin Replacement Study (HERS). Circulation. 2001, 103: 638-642. 10.1161/01.CIR.103.5.638.CrossRefPubMed

57.

Rossouw JE, Anderson GL, Prentice RL, LaCroix AZ, Kooperberg C, Stefanick ML, Jackson RD, Beresford SA, Howard BV, Johnson KC, Kotchen JM, Ockene J: Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women’s Health Initiative randomized controlled trial. JAMA. 2002, 288: 321-333. 10.1001/jama.288.3.321.CrossRefPubMed

58.

Stefanick ML: Postmenopausal hormone therapy and cardiovascular disease in women. Nutr Metab Cardiovasc Dis. 2010, 20: 451-458. 10.1016/j.numecd.2010.02.015.CrossRefPubMed

59.

de Villiers T, Gass M, Haines C, Hall J, Lobo R, Pierroz D, Rees M: Global consensus statement on menopausal hormone therapy. Maturitas. 2013, 74: 391-392. 10.1016/j.maturitas.2013.02.001.CrossRefPubMed

60.

Lin J, Caffrey J, Chang M, Lin Y: Sex, menopause, metabolic syndrome, and all-cause and cause-specific mortality–cohort analysis from the Third National Health and Nutrition Examination Survey. J Clin Endocrinol Metab. 2010, 95: 4258-4267. 10.1210/jc.2010-0332.CrossRefPubMed

61.

Spritzer PM, Oppermann K: Weight gain and abdominal obesity at menopause. Climacteric. 2013, 16: 292-10.3109/13697137.2012.753874.CrossRefPubMed

62.

Donato G, Fuchs S, Oppermann K, Bastos C, Spritzer P: Association between menopause status and central adiposity measured at different cutoffs of waist circumference and waist-to-hip ratio. Menopause. 2006, 13: 280-285. 10.1097/01.gme.0000177907.32634.ae.CrossRefPubMed

63.

Di Castelnuovo A, Costanzo S, Bagnardi V, Donati M, Iacoviello L, de Gaetano G: Alcohol dosing and total mortality in men and women: an updated meta-analysis of 34 prospective studies. Arch Intern Med. 2006, 166: 2437-2445. 10.1001/archinte.166.22.2437.CrossRefPubMed

64.

ESHRE Capri Workshop Group: Perimenopausal risk factors and future health. Hum Reprod Update. 2011, 17: 706-717.CrossRef

65.

Hardarson T, Gardarsdóttir M, Gudmundsson KT, Thorgeirsscon G, Sigvaldason H, Sigfússon N: The relationship between educational level and mortality. The Reykjavík Study. J Intern Med. 2001, 249: 495-502. 10.1046/j.1365-2796.2001.00834.x.CrossRefPubMed

The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1471-2458/14/194/prepub

Title: Causes of death and associated risk factors among climacteric women from Southern Brazil: a population based-study
Authors: Verônica Colpani
Karen Oppermann
Poli Mara Spritzer
Publication date: 01-12-2014
Publisher: BioMed Central
Published in: BMC Public Health / Issue 1/2014
Electronic ISSN: 1471-2458
DOI: https://doi.org/10.1186/1471-2458-14-194

At a glance: The STEP trials

Springer Medicine

Causes of death and associated risk factors among climacteric women from Southern Brazil: a population based-study

Abstract

Background

Methods

Results

Conclusion

At a glance: The STEP trials

Springer Medicine

Abstract

Background

Methods

Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 1/2014

HIV disclosure to sexual partner and associated factors among women attending ART clinic at Mekelle hospital, Northern Ethiopia

Design of a multi-site multi-state clinical trial of home monitoring of chronic disease in the community in Australia

Health-related on-pack communication and nutritional value of ready-to-eat breakfast cereals evaluated against five nutrient profiling schemes

Risk assessment for Thai population: benchmark dose of urinary and blood cadmium levels for renal effects by hybrid approach of inhabitants living in polluted and non-polluted areas in Thailand

Income-related inequalities in chronic conditions, physical functioning and psychological distress among older people in Australia: cross-sectional findings from the 45 and up study

Increasing the effectiveness of the Diabetes Prevention Program through if-then plans: study protocol for the randomized controlled trial of the McGill CHIP Healthy Weight Program